Novo Nordisk
NVO
#21
Rank
โ‚ฌ434.82 B
Marketcap
100,05ย โ‚ฌ
Share price
2.57%
Change (1 day)
5.72%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ10.66 Billion

According to Novo Nordisk's latest financial reports the company has โ‚ฌ10.66 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ4.05 B27.97%
2022-12-31โ‚ฌ3.16 B34.64%
2021-12-31โ‚ฌ2.35 B37.11%
2020-12-31โ‚ฌ1.71 B-17.23%
2019-12-31โ‚ฌ2.07 B-1.11%
2018-12-31โ‚ฌ2.09 B-17.32%
2017-12-31โ‚ฌ2.53 B-9.09%
2016-12-31โ‚ฌ2.78 B1.58%
2015-12-31โ‚ฌ2.74 B28.42%
2014-12-31โ‚ฌ2.13 B10.11%
2013-12-31โ‚ฌ1.93 B-10.15%
2012-12-31โ‚ฌ2.15 B-8.05%
2011-12-31โ‚ฌ2.34 B9.02%
2010-12-31โ‚ฌ2.15 B24.88%
2009-12-31โ‚ฌ1.72 B26.06%
2008-12-31โ‚ฌ1.36 B38.22%
2007-12-31โ‚ฌ0.98 B44.35%
2006-12-31โ‚ฌ0.68 B2.23%
2005-12-31โ‚ฌ0.67 B25.27%
2004-12-31โ‚ฌ0.53 B28.64%
2003-12-31โ‚ฌ0.41 B73.8%
2002-12-31โ‚ฌ0.23 B-51.76%
2001-12-31โ‚ฌ0.49 B155.03%
2000-12-31โ‚ฌ0.19 B7.13%
1999-12-31โ‚ฌ0.18 B88.36%
1998-12-31โ‚ฌ96.46 M-29.1%
1997-12-31โ‚ฌ0.13 B22.89%
1996-12-31โ‚ฌ0.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ9.45 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.34 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.69 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.92 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France